NEU 2.81% $18.65 neuren pharmaceuticals limited

Ann: Neuren completes enrolment in INTREPID clinical trial, page-9

  1. 3,043 Posts.
    lightbulb Created with Sketch. 249
    Staggering that they have had such difficulty recruiting for this trial - any ideas as to why?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.